At a glance
ClinicalIndex Comparison RecordN/ACompleted· 114 enrolled
Drug / intervention
Blood product transfusion based on conventional coagulation tests. +1 morebiological
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Prospective, Randomized Comparison Of Rapid Thrombelastography (r-TEG) And Conventional Coagulation Testing For Guiding The Diagnosis And Haemostatic Resuscitation Of Trauma Patients At Risk For Post-Injury Coagulopathy
In Brief
A clinical study evaluating Blood product transfusion based on conventional coagulation tests. and Blood product transfusion based on rapid thrombelastography (r-TEG) results. for Acute Coagulopathy. Completed, enrolled 114 participants across 1 site.
Detailed Summary
The purpose of this study is to compare rapid thrombelastography (r-TEG) with conventional coagulation testing for diagnosing and treating coagulation abnormalities in severely injured patients who are likely to require transfusion therapy.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAcute Coagulopathy
CountriesUnited States
CollaboratorsHaemonetics Corporation
Timeline
N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
Enrollment StartSep 2010
First PostedFeb 2012
Primary CompletionApr 2014
Study CompletionJul 2014
TodayJul 2026
First PostedFeb 22, 2012
Enrollment StartSep 1, 2010
Primary CompletionApr 1, 2014
Study CompletionJul 1, 2014
TodayJul 2, 2026
Enrollment to primary: 3.6 yearsPosted 14.4 years ago
Interventions
Blood product transfusion based on conventional coagulation tests.biological
Transfusion of blood products.
Blood product transfusion based on rapid thrombelastography (r-TEG) results.biological
Transfusion of blood products.